0001225208-16-031947.txt : 20160428
0001225208-16-031947.hdr.sgml : 20160428
20160428162244
ACCESSION NUMBER: 0001225208-16-031947
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160427
FILED AS OF DATE: 20160428
DATE AS OF CHANGE: 20160428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ballinger Kevin J.
CENTRAL INDEX KEY: 0001566080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 161600412
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2016-04-27
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001566080
Ballinger Kevin J.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP & Pres, Interven Cardio
Common Stock
2016-04-27
4
M
0
36630.0000
7.7100
A
83600.0000
D
Common Stock
2016-04-27
4
M
0
35000.0000
8.3000
A
118600.0000
D
Common Stock
2016-04-27
4
M
0
23077.0000
7.4100
A
141677.0000
D
Common Stock
2016-04-27
4
M
0
17100.0000
15.9100
A
158777.0000
D
Common Stock
2016-04-27
4
S
0
111807.0000
21.6156
D
46970.0000
D
Stock Option (Right to Buy)
7.4100
2016-04-27
4
M
0
23077.0000
0.0000
D
2020-02-16
Common Stock
23077.0000
0.0000
D
Stock Option (Right to Buy)
8.3000
2016-04-27
4
M
0
35000.0000
0.0000
D
2019-02-24
Common Stock
35000.0000
0.0000
D
Stock Option (Right to Buy)
7.7100
2016-04-27
4
M
0
36630.0000
0.0000
D
2018-10-28
Common Stock
36630.0000
0.0000
D
Stock Option (Right to Buy)
15.9100
2016-04-27
4
M
0
17100.0000
0.0000
D
2016-10-31
Common Stock
17100.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Represents the weighted average sale price. These shares were sold in multiple transactions at $21.40 and $22.00. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 16, 2010. This option is fully vested.
Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 24, 2009. This option is fully vested.
Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 28, 2008. This option is fully vested.
Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 31, 2006. This option is fully vested
/s/ Lee G. Giguere, Attorney-in-Fact
2016-04-28